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ABSTRACT
Patients with chronic kidney disease (CKD) tend to have hyperkalemia. They worry 
about the consumption of fruit for fear of increased serum potassium levels and therefore 
require a restricted potassium diet. Soursop fruit (Annona muricata Linn.) is believed to 
be beneficial for CKD and cardiovascular risk. This study was conducted to investigate 
the effect of soursop fruit supplement consumption on serum potassium levels and 
cardiovascular risk in prehypertension subjects from Mlati, Sleman District, Yogyakarta 
Special Region, Indonesia. A total 143 samples that met to the inclusion and exclusion 
criteria were subsequently randomized into two groups. Group I was given 2 x 100 g/day 
of soursop and Group II was without soursop. A laboratory examination from both groups 
was conducted including potassium, total cholesterol, low density lipoprotein (LDL), high 
density lipoprotein(HDL), and triglyceride levels at weeks 0; 7; and 13. Regular soursop 
consumption was evaluated every 2 weeks for 3 months. Data analysis was performed 
using an independent t test, a nonparametric Mann–Whitney test, and a chi-square test. 
No significantly different in serum potassium levels between the soursop and non-soursop 
groups at week 7 and 13 (p=0.073 and p=0.108) was observed. Furthermore, no significantly 
different in total cholesterol (p=0.254 and p=0.932), LDL (p=0.221 and p=0.710), HDL 
(p=0.400 and p=0.960), triglycerides (p=0.423 and p=0.580) of both groups was also 
obsereved. However, in subjects with hypercholesterolemia and hypertriglyceridemia, the 
mean cholesterol and triglyceride levels decreased compared to no soursop consumption 
at week 7 and 13. In conclusion, consumption of a soursop fruit supplement of 2 x 100 g/
day for 13 weeks does not affect the serum potassium levels of prehypertension subjects. 
Moreover, the consumption of a soursop fruit supplement is not significantly different 
compared to those without soursoup in improving cardiovascular risk.
ABSTRAK
Pasien penyakit ginjal kronik cenderung mengalami hiperkalemia. Mereka khawatir 
konsumsi buah karena takut kalium darahnya naik, oleh karena itu perlu restriksi diet 
kalium. Buah sirsak (Annona muricata Linn.) diduga bermanfaat untuk penyakit ginjal kronik 
dan risiko kardiovaskular. Penelitian ini dilakukan untuk mengkaji pengaruh pemberian 
minuman suplemen buah sirsak terhadap kadar kalium darah dan risiko kardiovaskular 
pada subjek prehipertensi dari Mlati, Sleman, Daerah Istimewa Yogyakarta. Total 143 
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subjek yang memenuhi kriteria inklusi dan eksklusi dibagi menjadi 2 kelompok. Kelompok I 
diberi suplemen buah sirsat 2 x 100 g/hari dan Kelompok II tanpa perlakuan. Pemeriksaan 
laboratorium dilakukan terhadap kalium, kolesterol total, LDL, HDL, trigliserida pada minggu 
ke 0; 7; dan 13. Evaluasi kepatuhan konsumsi sirsak setiap 2 minggu selama 3 bulan. 
Analisis data menggunakan uji t,  uji nonparametrik Mann-Whitney, dan uji Chi-Square. 
Tidak ada perbedaan bermakna pada kadar kalium darah pada minggu 7 dan 13 (p=0,073 
dan p=0,108) antara kelompok sirsak dan non sirsak.. Demikian juga tidak dijumpai 
perbedaan nyata kolesterol total (p=0,254 dan p=0,932), LDL (p=0,221 dan p=0,710), 
HDL (p=0,400 dan p=0,960), trigliserida (p=0,423 dan p=0,580) pada kedua kelompok. 
Tetapi pada subyek dengan hiperkolesterol dan hipertrigliserida rerata kadar kolesterol 
dan trigliserida turun pada minggu 7 dan 13 dibanding tanpa konsumsi sirsak. Dapat 
disimpulkan, konsumsi buah sirsak 2 x 100 g/hari selama 13 minggu tidak mempengaruhi 
kadar kalium darah subjek preipertensi. Selain itu, konsumsi buah sirsak tidak berbeda 
bermakna dibandingkan tanpa buah sirsak dalam memperbaiki risiko kardiovaskular.
Keywords: soursop – potassium – hyperkalemia - chronic kidney disease - cardiovascular
INTRODUCTION
Many patients with chronic kidney 
disease (CKD) assume that the consumption 
of fruit will increase serum potassium levels. 
Consumption of fruits that contain lots of 
potassium (apricots and bananas) causes 
hyperkalemia,1 especially in patients with 
impaired renal function. Hyperkalemia can 
lead to serious cardiac arrhythmias and death.2 
Several studies have suggested that soursop 
(Annona muricata Linn) consumption is 
beneficial for kidney disease.3 Surveys-
based studies have been conducted in various 
places including Peru4 and Bolivia5 on the 
use of soursop in the traditional treatment of 
kidney disease. Sja’bani (2014) reported that 
the consumption of 2x100 g/day soursop 
juice in patients with CKD in Yogyakarta, 
Indonesia decreased uric acid, serum ureum 
and creatinine, without adverse effects.6
The potassium content of soursop fruit 
is 278 mg/100g.3 The recommended intake 
of potassium in a standard diet is 4.7 g/
day (120 mmol/day); for mild to moderate 
CKD is <4.7 g/day, and for severe CKD 
(including those undergoing dial.  Soursop 
consumption of 2x100 g/day is equivalent to 
556 mg/day of potassium, this is well below 
the recommended dietary amountfor mild 
to severe CKD, even for those undergoing 
dialysis. However, whether the consumption 
of soursop fruit in patients with mild to 
severe CKD (undergoing hemodialysis) still 
safe and what is the effect of a soursop fruit 
supplement on serum potassium levels have 
not been investigated.
Cardiovascular disease has become 
a trend in medical talks in both developed 
and developing countries. Cardiovascular 
death by 31% from overall mortality rates,8 
otherwise, mortality rates due to infection 
tend to decrease. Various attempts have 
been made to reduce mortality due to 
cardiovascular disease by controlling blood 
pressure, diabetes, dyslipidemia, and even 
uric acid.
Hypertension is a major risk factor for 
increased morbidity and mortality due to 
cardiovascular, cerebrovascular, and end-
stage renal failure.9 Based on data from the 
2011–2012 NHANES survey, about one-third 
of adults in the United States are hypertensive. 
Hypertension is uncontrolled in almost half 
of these 71 million people, and of those 
with uncontrolled hypertension, about 36% 
or 13 million are unaware of the diagnosis. 
Even in patients in whom hypertension is 
diagnosed and treated, control is attained in 
only 60%. By convention, hypertension is 
categorized based on office measurements 
as stage 1 (140–159/90–99 mm Hg Within 
5 years, prehypertension increases the 
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risk of cardiovascular disease  by 45% 
compared to normal blood pressure.10  Once 
the importance of prehypertension became 
known, the ACC/AHA 2017 grouped it 
into stage I hypertension.11 Soursop fruit is 
expected to reduce blood pressure, decrease 
uric acid, and improve cardiovascular 
conditions by lowering cholesterol, LDL, 
and triglycerides and increasing HDL.12,13 
Soursop fruit contains tannins,14 which play 
a role in the reduction of triglycerides.15 
Soursop fruit also contains flavonoids,13 
which can inhibit the activity of the HMG-
CoA reductase enzyme in the cholesterol 
synthesis process. This is the necessary for 
in-depth research (randomized controlled 
trials, or RCTs) to determine the effect of 
soursop fruit supplementation compared 
to control serum potassium levels and 
cardiovascular risk.
MATERIALS AND METHODS
Design of study
This study represents in-depth 
epidemiology research on the effect of 
soursop fruit consumption in prehypertension 
with high normal uric acid. Prior to the 
study, the research design was approved 
by the Medical and Health Research Ethics 
Committee (MHREC) of the Faculty of 
Medicine, Public Healh and Nursing, 
Universitas Gadjah Mada/Dr. Sardjito 
General Hospital, Yogyakarta. After being 
given information about the study, subjects 
were asked to fill out and sign a willingness 
to participate form (informed consent).
Protocol of study
Data was taken from Mlati Study 10 
years ago; the selected subjects still have 
prehypertension, are 30–59 years old, and 
are located in the region of Mlati, Sleman, 
Yogyakarta, Indonesia. A random sample 
of the study was conducted using simple 
random sampling with SPSS 22 software. 
There were 143 samples that conform to 
the inclusion criteria of prehypertension, 
high normal uric acid (≥5 to <7 mg/dL), 
negative urine protein, and negative urine 
reduction. Exclusion criteria included a 
history of diabetes, chronic renal failure, 
use of hormonal contraception, pregnancy, 
hypertension, ages <30 or>59 years old, the 
consumption of uric-acid-lowering drugs 
(allopurinol, probenecid), uric acid levels 
<5 mg/dL or ≥ 7 mg/dL, creatinine levels > 
1.5 g/dL, and fasting blood glucose (FBG) 
> 126 g/dL. From 143 samples randomized 
to two groups, Group I was given 2x100 g/
day of soursop supplement and Group II was 
without soursop. Laboratory examinations 
of serum potassium, total cholesterol, LDL, 
HDL, and triglycerides were performed at 
weeks 0,7, and 13 in the soursop and non-
soursop groups. Compliance with the soursop 
consumption was evaluated every 2 weeks 
for 3 months. The study was conducted with 
RCTs. 
Statistical analysis
Data analysis was performed using an 
independent t test, a nonparametric Mann–
Whitney test, and a chi-square test.
RESULTS
The study involved 143 subjects, con-
sisted 71 subjects soursop and 72 subjects 
non-soursop groups. The 71 subjects sour-
sop group was 15 subjects (21%) are drop 
out at week 7 and 17 subjects (23%) at week 
13. The 72 subjects non-soursop group was 
12 subjects are drop out (16%) at week 7 and 
14 subjects (19%) at week 13. The mean age 
of the soursop group is 46.30 ± 7.95 years 
old, and the mean age of the non-soursop 
group is 44.44 ± 7.52 years old. There was 
no significant difference between the mean 
age of the two groups soursop and non-sour-
sop (p=0.107). The gender breakdown in 
the soursop group is 56 (79%) males and 15 
(21%) females, while the number of males in 
the non-soursop group is 51 (71%) and the 
number of females is 21 (29%). There was 
no significant difference between the males 
and females of the two groups soursop and 
non-soursop (p=0.268; TABLE 1).
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TABLE1. Age and gender in the soursop and non-soursopgroups.
Variable
Total Soursop Non-soursop
p
n=143 n=71 n=72
Age (mean ± SD years) 45.36 ± 7.76 46.30 ± 7.95 44.44 ± 7.52 0.107a
Gender [n (%)]
0.268a•	 Male 107 (74.8) 56 (39.2) 51 (35.7)
•	 Female 36 (25.2) 15 (10.5) 21 (14.7)
Note: at test, bMann–Whitney test.
TABLE 2. Mean potassium, total cholesterol, LDL, HDL, and triglycerides [mean (SD mg/
mL)] at weeks 0; 7; and 13 in the soursop and non-soursop groups.
Variable
Week 0 Week 7 Week 13
Soursop
n=71
Non-
soursop
n=72 p
Soursop
n=56
Non-
soursop
n=60 p
Soursop
n=54
Non-
soursop
n=58 p
Potassium
3.90
(0.35)
3.88
(0.32) 0.905b
4.09
(0.37)
3.99
(0.32) 0.073a
4.04
(0.30)
3.95
(0.36) 0.108a
Cholesterol
164.76 
(34.20)
167.81 
(34.33) 0.596a
191.59 
(27.86)
187.77 
(31.91) 0.254a
182.81 
(21.84)
185.86 
(28.26) 0.932a
LDL
108.51
(26.74)
109.04 
(30.78) 0.912a
127.57 
(21.72)
121.67 
(28.57) 0.221a
124.33 
(18.92)
121.95 
(27.21) 0.710a
HDL
41.54 
(10.11)
42.85 
(10.54) 0.449a
44.18 
(9.28)
44.30 
(11.85) 0.40a
45.30 
(10.03)
47.12 
(13.00) 0.960a
Triglycerides
118.54 
(69.25)
124.47 
(74.55) 0.634b
147.54 
(86.42)
168.32 
(198.05) 0.423b
138.81 
(60.82)
164.66 
(168.12) 0.580b
Note: at test, bMann–Whitney test
baseline total cholesterol levels in the two 
groups (p=0.596). At week 7, the soursop 
group level was 191.59 ± 27.86 mg/dL, and 
the non-soursop group level was 187.77 
± 31.91 mg/dL. There was no significant 
difference in the two groups (p=0.254). At 
week 13, the soursop group level was 182.81 
± 21.84 mg/dL, and the non-soursop group 
level was 185.86 ± 28.26 mg/dL.There was 
no significant difference in the two groups 
(p=0.932; TABLE 2).
The meanLDL level at baseline (week 
0) of the soursop group was 108.51 ± 26.74 
mg/dL, and the for the non-soursop group 
it was 109.04 ± 30.78 mg/dL. There was 
no significant difference in baseline LDL 
levels in the two groups (p=0.912). At week 
7, the soursop group level was 127.57 ± 
21.72 mg/dL, and in the non-soursop group 
it was 121.67 ± 28.57 mg/dL. There was 
The mean potassium level at baseline 
(week 0) of the soursop group was 3.90 ± 0.35 
mg/dL, and for the non-soursop group it was 
3.88 ± 0.32 mg/dL. There was no significant 
difference in the baseline potassium levels 
in the two groups (p=0.905). At week 7, the 
potassium level of the soursop group was 
4.09 ± 0.37 mg/dL, and in the non-soursop 
group it was 3.99 ± 0.32 mg/dL. There was 
no significant difference in the two groups 
(p=0.073). At week 13, the soursop group 
level was 4.04 ± 0.30 mg/dL, and the non-
soursop group level was 3.95 ± 0.36 mg/dL. 
There was no significant difference in the 
two groups (p=0.108; TABLE 2).
The mean total cholesterol level at 
baseline (week 0) of the soursop group was 
164.76 ± 34.20 mg/dL, and it was 167.81 
± 34.33 mg/dL in the non-soursop group. 
There was no significant difference in the 
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no significant difference in the two groups 
(p=0.221). At week 13, the soursop group 
level was 124.33±18.92 mg/dL, and the non-
soursop group level was 121.95±27.21 mg/
dL. There was no significant difference in 
the two groups (p=0.710; TABLE 2).
The mean HDL level at baseline (week 
0) of the soursop group was 41.54 ± 10.11 
mg/dL, and in the non-soursop group it 
was 42.85 ± 10.54 mg/dL. There was no 
significant difference in the baseline HDL 
levels in the two groups (p=0.449). At 
week 7, the soursop group level was 44.18 
± 9.28 mg/dL, and the non-soursop group 
level was 44.30 ± 11.85 mg/dL. There was 
no significant difference in the two groups 
(p=0.400). At week 13, the soursop group 
level was 45.30 ± 10.03 mg/dL, and the non-
soursop group level was 47.12 ± 13.00 mg/
dL. There was no significant difference in 
the two groups (p=0.960; TABLE 2).
The mean triglyceride level at baseline 
(week 0) of the soursop group was 118.54 ± 
69.25 mg/dL, and in the non-soursop group 
it was 124.47 ± 74.55 mg/dL. There was no 
significant difference in baseline triglyceride 
levels in the two groups (p=0.634). At week 
7, the soursop group level was 147.54 ± 
86.42 mg/dL, and the non-soursop group 
level was 168.32 ± 198.05 mg/dL. There 
was no significant difference in the two 
groups (p=0.423). At week 13, the soursop 
group level was 138.81 ± 60.82 mg/dL, and 
the non-soursop group level was 164.66 
± 168.12 mg/dL. There was no significant 
difference in the two groups (p=0.580; 
TABLE 2).
DISCUSSION
The recommended intake of potassium 
in a standard diet is 4.7 g/day (120 mmol/
day);for mildtomoderate CKD it is <4.7 g/
day, and in severe CKD (including those un-
dergoing dialysis) it is <3 g/day (TABLE 3).7 
Those with low-potassium diets are at risk 
for cardiac arrhythmias and constipation.
TABLE 3. Recommended dietary potassium intake in normal and CKD
Variable Normal Mild to moderate CKD Severe dialysis CKD
Potassium (g/day) 4.7 (120 mmol/day) < 4.7 (< 120 mmol/day) < 3 (< 77 mmol/day)
At week 7, the mean potassium levels of 
the soursop group increased from 3.90 ± 0.35 
to 4.09 ± 0.37 mg/dL, but in the non-soursop 
group there was also an increase from 3.88 ± 
0.32 to 3.99 ± 0.32 mg/dL. In the statistical 
analysis, there was no significant difference 
between the soursop and non-soursop groups 
(p=0.073). At week 13, the mean potassium 
levels of the soursop group increased from 
3.90 ± 0.35 to 4.04 ± 0.30 mg/dL, but in 
the non-soursop group there was also an 
increase from 3.88 ± 0.32 to 3.95 ± 0.36 mg/
dL. In the statistical analysis, there was no 
significant difference between the soursop 
and non-soursop groups (p=0.108). This 
study indicate soursop consumption 2x100 
g/day for 3 months there was no significant 
difference in serum potassium levels between 
the soursop and non-soursop groups. Soursop 
consumption of 2x100 g/day is equivalent to 
556 mg/day of potassium; this is well below 
the recommended dietary intakefor mild 
to severe CKD, even for those undergoing 
dialysis (TABLE 3). This meansthat the 
consumption of soursop fruit for patients 
with mild to severe CKD (dialysis) is still 
safe.
Several studies have suggested that 
soursop consumption is beneficial for 
kidney disease.3 Surveys-based studies have 
been conducted in various places including 
Peru4 and Bolivia5 on the use of soursop in 
the traditional treatment of kidney disease. 
Sja’bani,6 reported that the consumption of 
2x100 g/day soursop juice in patients with 
CKD in Yogyakarta, Indonesia can decrease 
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uric acid, serum ureum and creatinine, 
without causing negative effects.6
In a review journal of the NKF (National 
Kidney Foundation), the issue of whether a 
high-potassium diet restriction can prevent 
hyperkalemia in patients undergoing 
hemodialysis was explored. After study and 
data collection, it was found that a high-
potassium diet restriction was required to 
prevent hyperkalemia in patients undergoing 
hemodialysis.16 Patients with CKD tend to 
have hyperkalemia.17 They worry about the 
consumption of fruit for fear of increased 
serum potassium levels and therefore 
requirea restricted potassium diet. Soursop 
fruit is beneficial for CKD,6 and in this study 
the consumption of soursop was found to 
have no significant effect on potassium levels 
compared to the group without soursop. So 
the consumption of soursop on CKD is safe 
because it does not cause hyperkalemia and 
is beneficial because several other studies 
have stated about the benefits of soursop on 
kidney disease.
This cardiovascular risk study aims 
to examine the effect of the consumption 
of 2x100 g/day of soursop supplementon 
cardiovascular risk (total cholesterol, LDL 
cholesterol, HDL cholesterol, triglycerides). 
Soursop fruit contains tannins,14 which play 
a role in the reduction of triglycerides.15 
Soursop fruit also contains flavonoids,13 
which can inhibit the activity of the HMG-
CoA reductase enzyme in the cholesterol 
synthesis process. The inhibition of this 
enzyme activity results in the absence of 
mevalonate from HMG-CoA; mevalonate 
will be converted to squalene, lanosterol, 
dihydrolanosterol, D 8-dimethylsterol, 
7-dihydrocholesterol, and eventually 
cholesterol. In addition, flavonoids also have 
a positive effect in decreasing total cholesterol 
levels through the increased excretion of bile 
acids with feces. Tannins, riboflavin, and 
cyanide acid have a hypoglycemic effect 
that can lower cholesterol and triglyceride 
blood levels in mice.15,18
Flavonoids in soursop leaves and 
fruit are antioxidants that have the ability 
to reduce fat emulsion and cholesterol 
synthesis. Decreasing fat emulsions and 
cholesterol synthesis will lower the levels 
in the blood.18 Soursop fruit also contains 
many antioxidants.13 Most fruit is rich in 
antioxidant compounds that can prevent 
and inhibit damage from fats, proteins, and 
nucleic acids.19 The abundant antioxidants in 
fruit are polyphenols and vitamins (A, B, C 
and E) including flavonoids.20
The consumption of a soursop fruit 
supplement of 2x100 g/day for 3 months 
led to no significant difference in total 
cholesterol at week 7 (p=0.254) and week 
13 (p=0.932) between the soursop and 
non-soursop groups. For LDL cholesterol 
there was no significant difference at week 
7 (p=0.221) and week 13 (p=0.710). For 
HDL cholesterol there was no significant 
difference at week 7 (p=0.400) and week 
13 (p=0.960). There was no difference in 
triglyceride levels at week 7 (p=0.423) and 
week 13 (p=0.580) between the soursop and 
non-soursop groups.
No similar research has been conducted 
on the effect of soursop consumption on 
cardiovascular risk in humans, only in 
animals. Firmansyah et al.21 who administered 
soursop leaf extract to hyperglycemic rats, 
found that it did not lower total cholesterol 
and triglycerides significantly, but it 
decreased the blood sugar of mice. However, 
the administration of soursop leaf extract 
with ethyl acetate solvent can significantly 
decrease total blood cholesterol levels in 
mice.22 Likewise, Posangi et al.23 concluded 
that administeringsoursop leaf extract can 
reduce total cholesterol in mice.23
Pratiwi et al.24 found that the essenTia et 
al oil of soursop leaves (A. muricata Linn.) 
contains terpenoid, alkaloid, and phenolic 
compounds. Terpenoids, alkaloids, and 
phenolics serve as antioxidants and anti-
inflammatories in the right dosage. If the 
dose is high and administered for a long time, 
the terpenoids, alkaloids, and phenolics will 
become toxic and result in increased LDL 
and decreased HDL. A dosage of soursop 
leaf oil of 2.5 mg/kgW is a safe dose that 
does not increase LDL levels and decreases 
subchronic HDL levels in normal male and 
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female rats.24
Tia et al.25 reported the percentagesof 
decrease in the LDL cholesterol serum 
levels of white rats from various dosages of 
soursop juice: a dose of 0.9 g/200 g BW is 
equal to 46.19%, a dose of 1.8 g/200 g BW 
is equal to 52.30%, and a dose of 2.7 g/200 g 
BW is equal to 61.62%. There is an effect of 
administering various doses of soursop juice 
on the decrease in LDL cholesterol serum 
levels in white mouse dyslipidemia. The 
greater the dose of soursop juice, the greater 
the decrease in LDL cholesterol levels in the 
serum of white rats with dyslipidemia.25
de la Cruz et al.26 concluded that dried 
soursop fruit significantly lowers cholesterol, 
triglycerides, and LDL cholesterol in 
hyperlipidemic rats. The dosages of soursop 
fruit used were 500, 1000, 2000 mg/kgW. 
The higher the dose, the greater the decrease 
in cholesterol, triglyceride levels, and LDL 
levels. Syahida et al.27 showed that the 
higher the provision of soursop extract given 
to rats, the higher the level of antioxidants. 
Yuliantari et al.28 investigated the influence 
of temperature and extraction on the 
flavonoid content and antioxidant activity of 
soursop leaves. They showed that the best 
result is at a temperature of 45°C and a time 
of extraction of 20 min. The total yield is 
19.14% flavonoid 903.90 mgQE/g extract 
material, and the lowest antioxidant activity 
is 258.155 mg/L.28
Tugiyanti et al.18 showed that a soursop 
leaf supplement in male ducks of 8.36% 
showed the highest HDL level of 99.89 mg/
dL. However, a soursop flour supplement 
up to 15% had not been able to reduce 
triglycerides, cholesterol, and LDL blood 
levels in male ducks aged 10 weeks. Soursop 
leaves have antioxidant flavonoid content. 
Tugiyanti et al.18 stated that antioxidants can 
affect fat content. Wulandari et al.29 concluded 
that soursop leaf extract with ethanol solvent 
can lower triglyceride levels and increase 
HDL levels in male wistar rats. How does 
this study compare with other research on 
the effect of soursop on cardiovascular risk? 
TABLE 4 summaries briefly the study of 
soursop on cardiovascular risk.
TABLE 4. Comparison of this study with other soursop research on cardiovascular risk.
Haidar et al., 2018 Tia et al., 2014 Tugiyanti et al., 2016 de la Cruz et al., 2016
Material Soursop fruit juice Soursop fruit juice Soursop leaf flour Dried soursop fruit
Subject Healthy human Dyslipidemia mice Healthy ducks Dyslipidemia mice
Given by Oral Oral Oral Oral
Dose 2 x 100 g/day 0.9 g/200 g BW
1.8 g/200 g BW
2.7 g/200 g BW
Fodder+5%; 10%; 15% 
Soursop leaf flour
500 mg/kg BW
1000 mg/kg BW
2000 mg/kg BW
Method Cohort, 3 months, 
RCT
Control group 
design
Completely randomized 
design, 5 weeks
Completely randomized 
design, 30 days
Evaluation Every 2 weeks Pre- and post-test Pre- and post-test Pre- and post-test
Result No significant effect 
on the decrease in total 
cholesterol, LDL, or 
triglycerides and an 
increase in HDL at 
week 7 and 13 in the 
soursop and non-
soursop groups.
There is the effect 
of giving various 
doses of soursop 
juice on the decrease 
in LDL cholesterol 
levels. The greater 
the dose, the greater 
the decrease in LDL 
cholesterol levels.
Cannot lower 
triglycerides, cholesterol, 
and blood LDL and 
triglyceride levels
Significantly lower 
cholesterol, triglycerides, 
and LDL. The higher 
the dose, the greater the 
decrease.
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In a study on dyslipidemia in mice, 
Tia et al.25 found that soursop juice can 
lower LDL. Research by de la Cruz et al.26 
on dyslipidemia in mice concluded that 
soursop can lower cholesterol, triglycerides, 
and LDL. This study found that soursop 
juice in healthy humans had no significant 
effect in decreasingcholesterol, LDL, or 
triglycerides, and HDL increased in the 7th 
and 13th weeks for the soursop and non-
soursop groups. Why is there no significant 
difference in total cholesterol, LDL, HDL, 
or triglycerides among the soursop and non-
soursop groups at weeks 7 and 13?  We 
suspect that the subjects of the study were 
healthy subjects rather than subjects with 
cardiovascular disorders (dyslipidemia) as 
in other studies. When the subjects who had 
dyslipidemia (hypercholesterolemia, high 
LDL, low HDL, and hypertriglyceridemia) 
are compared to the soursop and non-
soursop groups, the resultsare as presented 
in TABLE 5. 
TABLE 5. Subject dyslipidemia [mean (SD)] in the soursop and non-soursop groups.
Hypercholesterol 
(mg/dL)
Week 0(n = 22) Week 7(n = 17) Week 13(n = 17)
Soursop
(n = 10)
Non-soursop
(n = 12)
Soursop
(n = 7)
Non-soursop
(n = 10)
Soursop
(n = 7)
Non-soursop
(n = 10)
221.30
(17.30)
223.25
(15.88)
213.57
(19.67)
223.70
(25.06)
197.57
(33.64)
220.70
(18.06)
High LDL 
(mg/dL)
Week 0(n = 81) Week 7(n = 63) Week 13(n = 61)
Soursop
(n = 42)
Non-soursop
(n = 39)
Soursop
(n = 33)
Non-soursop
(n = 30)
Soursop
(n = 32)
Non-soursop
(n = 29)
126.86
(16.75)
131.69
(21.53)
135.73
(20.44)
137.07
(24.38)
130.53
(18.20)
134.24
(26.61)
Low HDL 
(mg/dL)
Week 0(n = 60) Week 7(n = 49) Week 13(n = 46)
Soursop
(n = 32)
Non-soursop
(n = 28)
Soursop 
(n = 26)
Non-soursop
(n = 23)
Soursop 
(n = 25)
Non-soursop
(n = 21)
32.50
(5.00)
32.54
(4.69)
40.15
(8.63)
40.61
(10.57)
41.12
(7.73)
42.19
(13.43)
Hypertriglyceride 
(mg/dL)
Week 0(n = 35) Week 7(n = 29) Week 13(n = 28)
Soursop
(n = 18)
Non-soursop
(n = 17)
Soursop 
(n = 14)
Non-soursop
(n = 15)
Soursop 
(n = 14)
Non-soursop
(n = 14)
205.28
(83.52)
233.47
(77.80)
183.07
(90.76)
339.67
(342.53)
188.29
(64.51)
324.21
(276.16)
There were 22 subjects with 
hypercholesterolemia at week 0 and 17 at 
weeks 7and 13. The mean value for subjects 
with hypercholesterolemia who consumed 
soursop at week 7 showed decreased 
cholesterol averages from 221  to 213 mg/
dL. At week 13, the average value for 
cholesterol decreased from 221  to 197 mg/
dL when compared with week 0. From week 
7 to week 13, the average cholesterol value 
decreased from 213 to 197 mg/dL.
Regarding the mean value for subjects 
with hypercholesterolemia without soursop 
consumption, at week 7 cholesterol did not 
decrease (it stayed at 223 mg/dL). At week 
13, the value of the cholesterol average 
decreased from 223 mg/dL to 220 mg/
dL when compared with week 0. Without 
soursop consumption in subjects with 
hypercholesterolemia, there was almost no 
changefor 13 weeks. From this study, it can 
be concluded that the consumption of soursop 
fruit in subjects with hypercholesterolemia 
can reduce cholesterol averages at weeks 7 
and 13 compared to the group without the 
consumption of soursop.
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There were 81 subjects with high LDL 
at week 0, 63 subjects at week 7, and 61 
subjects at week 13. The mean value for high 
LDL subjects in the soursop consumption 
group at week 7 increased from 126 to 135 
mg/dL and at week 13 from 126 to 130 mg/
dL. Regarding the mean values for high 
LDL subjects without soursop, at week 7the 
average LDL increased from 131 to 137 
mg/dL. At week 13, the mean LDL value 
increased from 131 to 134 mg/dL when 
compared with week 0. From this research, 
it can be concluded that the consumption 
of soursop fruit in subjects with high 
LDL did not lower mean LDL at weeks 7 
and 13 compared to the group without the 
consumption of soursop.
There were 60 subjects with low HDL 
at week 0, 49 subjects at week 7, and 46 
subjects at week 13. The mean value for low 
HDL subjects with soursop consumption 
increasedat week 7 and week 13from 32 to 
40 and 41 mg/dL, respectively. Regarding 
the mean value for low HDL subjects 
without soursop consumption, at weeks 7 
and 13 it increased from 32 to 40 and 42 mg/
dL, respectively. From this study, it can be 
concluded that the consumption of soursop 
fruit does not increase mean HDL cholesterol 
compared to the non-soursop group.
There were 35 subjects with 
hypertriglyceridemia at week 0, 29 subjects 
at week 7, and 28 subjects at week 13. The 
mean value for hypertriglyceridemia subjects 
with the consumption of soursop decreased 
from 205 to 183 mg/dL and 188 mg/dL, 
respectively, at weeks 7and 13. Regarding 
the mean value for hypertriglyceridemia 
subjects without soursop consumption, at 
weeks 7 and 13, it increased from 233 to 
339 mg/dL and 324 mg/dL, respectively. 
From this study, it can be concluded that 
the consumption of soursop fruit can lower 
mean triglyceride levelscompared to the 
group without soursop consumption.
CONCLUSION
In conclusion, consumption of a sour-
sop fruit supplement of 2 x 100 g/day for 
13 weeks does not affect the serum potas-
sium levels of prehypertension subjects. 
Moreover, the consumption of a soursop 
fruit supplement is not significantly differ-
ent compared to those without soursoup in 
improving cardiovascular risk as expressed 
by the decrease total cholesterol, LDL, and 
triglycerides and the increase HDL. How-
ever, in subjects with hypercholesterolemia 
and hypertriglyceridemia, the consumption 
of soursop fruit for 13 weeks decreases the 
cholesterol and triglyceride levels at weeks 
7 and 13 compared to those wihout soursop 
fruit supplement.
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